Natera
| Formerly | Gene Security Network, Inc. (2004–2012) |
|---|---|
| Company type | Public |
| |
| Industry | Genetic testing |
| Founded | 2004 |
| Founders |
|
| Headquarters | Austin, Texas, U.S. |
Key people |
|
| Revenue | US$797 million (2022) |
| US$−541 million (2022) | |
| US$−548 million (2022) | |
| Total assets | US$1.39 billion (2022) |
| Total equity | US$706 million (2022) |
Number of employees | 3,018 (2022) |
| Website | natera |
| Footnotes / references | |
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.